Divergent Resistance Mechanisms to Immunotherapy Explain Responses in Different Skin Cancers

SIMPLE SUMMARY: Despite the successes of immune checkpoint therapy in treating metastatic skin cancers, most patients either fail to respond or become unresponsive to immunotherapy. We found that the cell–cell communication of two different immune cell types, macrophages and memory B cells, correlat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dollinger, Emmanuel, Bergman, Daniel, Zhou, Peijie, Atwood, Scott X., Nie, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599806/
https://www.ncbi.nlm.nih.gov/pubmed/33065980
http://dx.doi.org/10.3390/cancers12102946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599806/
https://www.ncbi.nlm.nih.gov/pubmed/33065980
http://dx.doi.org/10.3390/cancers12102946

Ejemplares similares